13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
|
Name |
WKN |
Börse |
Kurs |
Datum/Zeit |
Diff. |
Diff. % |
Geld |
Brief |
Erster |
Schluss |
![](/mel/img/quote_button.gif) |
SANOFI SA INHABER EO 2 |
920657 |
Frankfurt |
87,250 |
17.06.24 19:28:41 |
+0,550 |
+0,63% |
0,000 |
0,000 |
86,300 |
86,700 |
![](/mel/img/quote_button.gif) |
REGENERON PHARMAC.DL-,001 |
881535 |
Frankfurt |
975,800 |
17.06.24 19:14:09 |
+23,000 |
+2,41% |
0,000 |
0,000 |
967,800 |
952,800 |